MedPath

Impact of Sleep Apnea on Sepsis Mortality

Conditions
Sleep Apnea Syndromes
Mortality
Sepsis
Interventions
Biological: OSA
Registration Number
NCT03654456
Lead Sponsor
Taipei Veterans General Hospital, Taiwan
Brief Summary

By clinical record review, this retrospective study aims to compare the mortality of sepsis patients with versus without obstructive sleep apnea, who were diagnosed and treated in Taipei Veterans General Hospital, Taiwan.

Detailed Description

This retrospective study aims to compare the mortality of sepsis patients with versus without obstructive sleep apnea (OSA). Patients with a diagnosis of sepsis, who had received a prior polysomnography at Taipei Veterans General Hospital during Jan. 1, 2001 to May 31, 2017 will be enrolled. Obstructive sleep apnea (OSA) is defined by an apnea-hypopnea index at least 5/hr with compatible symptoms. Their clinical record will be reviewed and data including demography, polysomnography and details related to sepsis (source of infection, number of organ dysfunction at initial diagnosis of sepsis and survival time) will be collected. The start of the survival time (follow-up time) is the date when sepsis is diagnosed. The end of the survival time (follow-up time) is the date of death or end of hospitalization (date of discharge). Survival analyses will be performed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
280
Inclusion Criteria
  1. Patients who received received a polysomnography at Taipei Veterans General Hospital during Jan. 1, 2001 to May 31, 2017
  2. Patients who were admitted with a diagnosis of sepsis after the polysomnography
  3. The diagnosis of sepsis fulfilling the clinical criteria
Exclusion Criteria
  1. Younger than 20 years
  2. Not compatible with a definition of sepsis
  3. subjects with incomplete data

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Sepsis patients with OSAOSASepsis patients who received a prior polysomnography showing an apnea-hypopnea index at least 5/hr with compatible symptoms
Primary Outcome Measures
NameTimeMethod
Mortalityup to 40 days

percentage of sepsis patients died of sepsis

Secondary Outcome Measures
NameTimeMethod
Mortality28-day

percentage of sepsis patients died of sepsis

Survival timeup to 40 days

Survival time is defined as the length from the date when sepsis is diagnosed to date of discharge or death

Trial Locations

Locations (1)

Taipei Veterans General Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath